|
SGEN's Revenue Growth by Quarter and Year
Seagen Inc 's Revenue results by quarter and year
Select the Comparisons :
|
|
Select the Ratio:
|
|
SGEN Revenue (in millions $) |
FY 2023 |
FY 2022 |
FY 2021 |
FY 2020 |
IV Quarter |
December |
-
|
528.15
|
429.85
|
601.29
|
III Quarter |
September |
648.65
|
510.30
|
424.06
|
1,061.73
|
II Quarter |
June |
603.83
|
497.50
|
388.48
|
278.00
|
I Quarter |
March |
519.72
|
426.46
|
331.98
|
234.51
|
FY |
|
1,772.20
|
1,962.41
|
1,574.37
|
2,175.53
|
SGEN Revenue third quarter 2023 Y/Y Growth Comment |
Seagen Inc reported Revenue improvement of 27.11% year on year in the third quarter 2023, to $ 648.65 millions, this is lower than Seagen Inc 's recent average Revenue improvement of 29.35%.
Looking into third quarter 2023 results within Biotechnology & Pharmaceuticals industry 5 other companies have achieved higher Revenue growth. While Seagen Inc ' s Revenue rise of 27.11% ranks overall at the positon no. 736 in the third quarter 2023.
|
SGEN Revenue ( Y/Y Growth %) |
2023
|
2022 |
2021 |
2020 |
IV Quarter |
December |
- |
22.87 % |
-28.51 % |
107.48 % |
III Quarter |
September |
27.11 % |
20.34 % |
-60.06 % |
397.86 % |
II Quarter |
June |
21.37 % |
28.06 % |
39.74 % |
27.26 % |
I Quarter |
March |
21.87 % |
28.46 % |
41.56 % |
20.14 % |
FY |
|
- |
24.65 % |
-27.63 % |
137.32 % |
SGEN Revenue (Quarter on Quarter Growth %) |
2023
|
2022 |
2021 |
2020 |
IV Quarter |
December |
- |
3.5 % |
1.37 % |
-43.37 % |
III Quarter |
September |
7.42 % |
2.57 % |
9.16 % |
281.92 % |
II Quarter |
June |
16.18 % |
16.66 % |
17.02 % |
18.55 % |
I Quarter |
March |
-1.6 % |
-0.79 % |
-44.79 % |
-19.08 % |
FY (Year on Year) |
|
- |
24.65 % |
-27.63 % |
137.32 % |
Revenue Y/Y Growth Statistics |
High |
Average |
Low |
137.76 % |
29.35 % |
-27.63 % |
(Mar 31 2021) |
|
(Dec 31 2021) |
|
Revenue Y/Y Growth Statistics |
High |
Average |
Low |
137.76 % |
29.35 % |
-27.63 % |
(Mar 31 2021) |
|
(Dec 31 2021) |
|
Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023 |
Seagen Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics |
High |
Average |
Low |
281.92 % |
10.19 % |
-44.79 % |
(Sep 30 2020) |
|
|
SGEN's III. Quarter Q/Q Revenue Comment |
Seagen Inc achieved in the III. Quarter 2023 below company average Revenue increase of 7.42% quarter on quarter, to $ 648.65 millions.
III. Quarter 2023 SGEN's performance were paradoxical, although beneath the regular growth of 10.19 %, yet it demonstrates real acceleration relative to the 2.57% in the III. Quarter a year ago.
Within Biotechnology & Pharmaceuticals industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Seagen Inc 's Revenue growth quarter on quarter, overall rank is 286. |
|
|
Revenue Q/Q Growth Statistics |
High |
Average |
Low |
281.92 % |
10.19 % |
-44.79 % |
(Sep 30 2020) |
|
|
SGEN's III. Quarter Q/Q Revenue Comment |
Seagen Inc achieved in the III. Quarter 2023 below company average Revenue increase of 7.42% quarter on quarter, to $ 648.65 millions.
III. Quarter 2023 Revenue sequential growth seem to be paradoxical, albeit beneath the regular, yet it demonstrates absolute acceleration measured to the 2.57% in the III. Quarter 2022 Cristina Sanz, a business observer mentioned.
Within Biotechnology & Pharmaceuticals industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Seagen Inc 's Revenue growth quarter on quarter, overall rank is 286. |
|
Seagen Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending (Sep 30 2023) |
12 Months Ending (Jun 30 2023) |
12 Months Ending (Mar 31 2023) |
12 Months Ending (Dec 31 2022) |
12 Months Ending (Sep 30 2022) |
Cumulative Revenue 12 Months Ending |
$ 2,300.35 |
$ 2,162.00 |
$ 2,055.67 |
$ 1,962.41 |
$ 1,864.11 |
Y / Y Revenue Growth (TTM) |
23.4 % |
21.61 % |
23.18 % |
24.65 % |
6.78 % |
Year on Year Revenue Growth Overall
Ranking |
# 1627 |
# 744 |
# 3346 |
# 2213 |
# 270 |
Seqeuential Revenue Change (TTM) |
6.4 % |
5.17 % |
4.75 % |
5.27 % |
4.85 % |
Seq. Revenue Growth (TTM) Overall
Ranking |
# 1794 |
# 431 |
# 2078 |
# 2062 |
# 96 |
Cumulative Revenue growth
Comment |
Although Seagen Inc 's Annual Revenue growth year on year were below company's average 29.35% , Revenue announced in the Sep 30 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 23.4% year on year, from 21.61% in Jun 30 2023.
In the Healthcare sector 288 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 744 to 1627. |
Revenue TTM Q/Q Growth Statistics |
High |
Average |
Low |
137.76 % |
29.35 % |
-27.63 % |
|
|
|
|
|
Revenue TTM Y/Y Growth Statistics |
High |
Average |
Low |
137.76 % |
29.35 % |
-27.63 % |
|
|
|
Revenue TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 29 |
Sector |
# 306 |
S&P 500 |
# 1794 |
|
Cumulative Revenue growth
Comment |
Although Seagen Inc 's Annual Revenue growth year on year were below company's average 29.35% , Revenue announced in the Sep 30 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 23.4% year on year, from 21.61% in Jun 30 2023.
In the Healthcare sector 288 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 744 to 1627. |
Revenue TTM Q/Q Growth Statistics |
High |
Average |
Low |
137.76 % |
29.35 % |
-27.63 % |
|
|
|
Revenue TTM Y/Y Growth Statistics |
High |
Average |
Low |
137.76 % |
29.35 % |
-27.63 % |
|
|
|
Revenue TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# 29 |
Sector |
# 306 |
S&P 500 |
# 1794 |
|